Search research articles
Contact Us
Filters
Showing results (561-570 of 722) with videos related to
Page
of 73
Sort By:
Oncology Reports
|
April 24, 2020
MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway
Chen-Yang Meng, Zhen-Qun Zhao, Rui Bai, et al.
Scientific Reports
|
November 16, 2024
A novel role of peroxiredoxin 2 in diabetic kidney disease progression by activating the classically activated macrophages
Xia Li, Hehua Long, Rui Peng, et al.
International Journal of Clinical and Experimental Pathology
|
January 11, 2021
The role of Stim1 in the progression of lupus nephritis in mice
Fan Zhang, Xingcheng Zhou, Daolin Cui, et al.
Infection and Drug Resistance
|
February 29, 2020
Carbapenem-Resistant <i>Enterobacter hormaechei</i> ST1103 with IMP-26 Carbapenemase and ESBL Gene <i>bla</i> <sub>SHV-178</sub>
Jian-Jun Gou, Na Liu, Li-Hua Guo, et al.
Journal of Cellular and Molecular Medicine
|
March 15, 2018
S1PR3 is essential for phosphorylated fingolimod to protect astrocytes against oxygen-glucose deprivation-induced neuroinflammation via inhibiting TLR2/4-NFκB signalling
Yin-Feng Dong, Ruo-Bing Guo, Juan Ji, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 18, 2023
Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3K<i>α</i> inhibitors
Rui Chen, Zhongyuan Wang, Lijie Sima, et al.
Environmental Geochemistry and Health
|
April 9, 2024
Long-term exposure to fine particulate matter constituents in relation to chronic kidney disease: evidence from a large population-based study in China
Yucen Dai, Jianzhong Yin, Sicheng Li, et al.
Iscience
|
February 2, 2024
Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics
Rui Peng, Siyang Zuo, Xia Li, et al.
Journal of Cellular Physiology
|
May 16, 2021
Identification of YAP1 as a novel downstream effector of the FGF2/STAT3 pathway in the pathogenesis of renal tubulointerstitial fibrosis
Xiaoying Li, Fan Zhang, Lingling Qu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
August 3, 2021
YAP1 Overexpression Is Associated with Kidney Dysfunction in Lupus Nephritis
Ying Xie, Yuanyuan Ruan, Huimei Zou, et al.
Page
of 73
Search research articles
Search
Showing results (561-570 of 722) with videos related to
Sort By:
Page
of 73
Oncology Reports
|
April 24, 2020
MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway
Chen-Yang Meng, Zhen-Qun Zhao, Rui Bai, et al.
Scientific Reports
|
November 16, 2024
A novel role of peroxiredoxin 2 in diabetic kidney disease progression by activating the classically activated macrophages
Xia Li, Hehua Long, Rui Peng, et al.
International Journal of Clinical and Experimental Pathology
|
January 11, 2021
The role of Stim1 in the progression of lupus nephritis in mice
Fan Zhang, Xingcheng Zhou, Daolin Cui, et al.
Infection and Drug Resistance
|
February 29, 2020
Carbapenem-Resistant <i>Enterobacter hormaechei</i> ST1103 with IMP-26 Carbapenemase and ESBL Gene <i>bla</i> <sub>SHV-178</sub>
Jian-Jun Gou, Na Liu, Li-Hua Guo, et al.
Journal of Cellular and Molecular Medicine
|
March 15, 2018
S1PR3 is essential for phosphorylated fingolimod to protect astrocytes against oxygen-glucose deprivation-induced neuroinflammation via inhibiting TLR2/4-NFκB signalling
Yin-Feng Dong, Ruo-Bing Guo, Juan Ji, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 18, 2023
Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3K<i>α</i> inhibitors
Rui Chen, Zhongyuan Wang, Lijie Sima, et al.
Environmental Geochemistry and Health
|
April 9, 2024
Long-term exposure to fine particulate matter constituents in relation to chronic kidney disease: evidence from a large population-based study in China
Yucen Dai, Jianzhong Yin, Sicheng Li, et al.
Iscience
|
February 2, 2024
Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics
Rui Peng, Siyang Zuo, Xia Li, et al.
Journal of Cellular Physiology
|
May 16, 2021
Identification of YAP1 as a novel downstream effector of the FGF2/STAT3 pathway in the pathogenesis of renal tubulointerstitial fibrosis
Xiaoying Li, Fan Zhang, Lingling Qu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
August 3, 2021
YAP1 Overexpression Is Associated with Kidney Dysfunction in Lupus Nephritis
Ying Xie, Yuanyuan Ruan, Huimei Zou, et al.
Page
of 73